Approval for allotment of 58,00,000 (Fifty Eight Lakhs) Equity Shares of Re.1/- at a premium of Rs.5/- per equity share on preferential basis to Promoter and Non-Promoter group under the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 2.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Achyut Healthcare approved the allotment of 58,00,000 equity shares of face value ₹1 each at a premium of ₹5 per share, i.e., at ₹6 per share, on a preferential basis. The total consideration of ₹3.48 crore has been received from the allottees. The shares were issued to a mix of promoter entities (Akshit Mahendra Raycha, Mahendra C. Raycha HUF, Ray Remedies, Zenith Lifecare) and non-promoter allottees (Dhavalkumar Ruparelia, Mayankbhai Ruparelia, Strikar Lifescience LLP). After this allotment, the company's paid-up equity capital will increase from 23,55,57,000 shares to 24,13,57,000 shares.
This is a small preferential raise of about ₹3.48 crore, with the promoter group also subscribing, which signals promoter confidence. However, the dilution is marginal (about 2.5% increase in share count) and the issue is to a limited set of allottees, so price impact is expected to be limited.